Oppenheimer & Co’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-4,000
Closed -$254K 1498
2013
Q3
$254K Buy
+4,000
New +$254K 0.01% 1047